🇺🇸 FDA
Pipeline program

XEOMIN 100 unités, poudre pour solution injectable, Placebo of Xeomin 100 UI, powder for injection

APHP210416

Phase 2 small_molecule active

Quick answer

XEOMIN 100 unités, poudre pour solution injectable, Placebo of Xeomin 100 UI, powder for injection for Degenerative shoulder rotator cuff tendinopathy is a Phase 2 program (small_molecule) at Pari Pharma GmbH with 1 ClinicalTrials.gov record(s).

Program details

Company
Pari Pharma GmbH
Indication
Degenerative shoulder rotator cuff tendinopathy
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials